September Slide, Vaccine Optimism & Stimulus Talks Back On Table

Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.